MAP1LC3C and non-small cell lung carcinoma: Consistent with these observations, single-cell transcriptomic analysis of a small cohort of 7 NSCLC tumors (GSE127465) [48] confirmed that MAP1LC3C expression is associated with HLA class II, HLA chaperone (HLA-DMA) and CIITA (Fig 2A) expression.